3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
8
Thoracic
4
Plasma cell
3
Dermatologic
3
CNS
3
Sarcoma
2
Lymphoid
2
Head & Neck
2
Genitourinary
2
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Surveys and Questionnaires
8
Blood Specimen Collection
7
lutetium Lu 177 dotatate
6
Surgical Procedures, Operative
6
Magnetic Resonance Spectroscopy
6
Adrenalectomy
5
Observation
4
Transurethral Resection of Prostate
3
Thyroidectomy
3
Positron-Emission Tomography
3
Lymph Node Excision
3
Data Collection
3
telotristat ethyl
2
surufatinib
2
gallium Ga 68 dotatate
2
Somatostatin
2
Radionuclide Imaging
2
Radiofrequency Ablation
2
Everolimus
2
Drug Therapy
2
Biopsy
2
somapacitan
1
methyl hydroxyethyl cellulose
1
lanreotide
1
fluorodopa F 18
1
exemestane
1
delta 24-sterol reductase
1
copper dotatate CU-64
1
Whole Body Imaging
1
Walking
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Patient Reported Outcome Measures
×
Endocrine
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled